VQF-13091-72325
3 vaccinations
5 coded responses
34 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 981 / WA
- Registered
- 2022-06-26
- Relationship
- Child or adolescent in my care
- Guardian
- 5T8-19595-54995
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-25
Dose 1 — Moderna
-
2022-06-26
Registered in v-safe
- 2022-06-26
- 2022-06-28
-
2022-06-29
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Good · Irritability/cryingUnder 3 check-in
- 2022-06-30
- 2022-07-01
-
2022-07-04
Health check-in — day 7, dose 1, under 3Feeling: Good · Site: Redness, Swelling/hardness · NoneUnder 3 check-in
- 2022-07-09
- 2022-07-16
-
2022-07-23
Dose 2 — Moderna
- 2022-07-23
-
2022-07-24
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Fair · Fever · Irritability/cryingUnder 3 check-in
- 2022-07-25
-
2022-07-26
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Good · Irritability/cryingUnder 3 check-in
- 2022-07-27
- 2022-07-28
- 2022-07-29
- 2022-07-30
- 2022-08-06
-
2022-08-13
Survey response — day 21, dose 2, under 3MedDRA: Rhinorrhoea — Feeling: FairFree text: Runny noseMedDRA releases: 2024-11 · check-in free text available
- 2022-08-20
- 2022-08-27
-
2022-09-03
Survey response — day 42, dose 2, under 3MedDRA: Pyrexia, Rash, Rhinorrhoea — Feeling: Fair · Be unable to work or attend schoolFree text: Fever, runny nose, rashMedDRA releases: 2024-11 · check-in free text available
- 2022-10-22
-
2022-12-31
Dose 3 — Moderna
- 2022-12-31
-
2023-01-01
Health check-in — days 1–6 daily, dose 3, under 3Feeling: Good · Irritability/cryingUnder 3 check-in
- 2023-01-02
- 2023-01-03
- 2023-01-04
- 2023-01-05
- 2023-01-07
- 2023-01-14
-
2023-01-28
Survey response — day 28, dose 3, under 3MedDRA: Rhinorrhoea — Feeling: FairMedDRA releases: 2024-11
- 2023-02-04
-
2023-02-11
Survey response — day 42, dose 3, under 3MedDRA: Rhinorrhoea — Feeling: GoodMedDRA releases: 2024-11
-
2023-04-01
Survey response — 3 months, dose 3, under 3MedDRA: Nasopharyngitis — Feeling: GoodMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-25 | Moderna | No |
| 2 | 2022-07-23 | Moderna | No |
| 3 | 2022-12-31 | Moderna | No |
Free text
Release 12 (Under 3) — day 21, dose 2, under 3
Symptoms: Runny nose
Release 12 (Under 3) — day 42, dose 2, under 3
Symptoms: Fever, runny nose, rash
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rash | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release